Src kinase inhibitor PP2 increases intrinsic gemcitabine sensitivity and attenuates acquired resistance in pancreatic cancer cells.
Year: 2003
Type: article
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1479904201
